Non-linearities occur no more frequently between microdose and therapeutic dose studies than in therapeutic range ascending-dose studies. Most non-linearities are due to known saturable processes, and can be foreseen by integrating commonly available preclinical data. The guidance presented here may support decision making on incorporating a microdosing study in drug development
Microdosing provides a tool to enhance drug development by initiating human studies prior to Phase I...
Microdosing is a new concept in drug development that-if implemented in the pharmaceutical industry-...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...
The concept of microdosing has been around for more than a decade. It consists of the subpharmacolog...
Drug development pipelines are plagued by increasing costs and decreasing productivity, so technique...
Introduction: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
Background: Microdosing studies (human Phase 0) are used to select drug candidates for Phase I clini...
INTRODUCTION: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
The concept of microdosing has been around for approximately 10 years. In this time there have been ...
Drug development is an activity that is long, complex and expensive. In 2004, attrition in the drug ...
The development of new drugs for life threatening diseases is an expensive, risky and time-consuming...
Phase 0 microdose trials are exploratory studies to early assess human pharmacokinetics of new chemi...
The use of microdose pharmacokinetic studies as an essential tool in drug development is still to ca...
Microdosing provides a tool to enhance drug development by initiating human studies prior to Phase I...
Microdosing is a new concept in drug development that-if implemented in the pharmaceutical industry-...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...
The concept of microdosing has been around for more than a decade. It consists of the subpharmacolog...
Drug development pipelines are plagued by increasing costs and decreasing productivity, so technique...
Introduction: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
Background: Microdosing studies (human Phase 0) are used to select drug candidates for Phase I clini...
INTRODUCTION: Microdosing is an approach to early drug development where exploratory pharmacokinetic...
The concept of microdosing has been around for approximately 10 years. In this time there have been ...
Drug development is an activity that is long, complex and expensive. In 2004, attrition in the drug ...
The development of new drugs for life threatening diseases is an expensive, risky and time-consuming...
Phase 0 microdose trials are exploratory studies to early assess human pharmacokinetics of new chemi...
The use of microdose pharmacokinetic studies as an essential tool in drug development is still to ca...
Microdosing provides a tool to enhance drug development by initiating human studies prior to Phase I...
Microdosing is a new concept in drug development that-if implemented in the pharmaceutical industry-...
Microdosing, or human phase 0 clinical trials, is a technique whereby subpharmacological doses of pr...